Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
370.00    -8.00 (-2.12%)
Bid:
370.00
Ask:
380.00
Spread: 10.00 (2.703%)
Market Cap: £147.90m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Directorate Change - CFO appointment

3 Jun 2020 07:00

RNS Number : 7395O
Dialight PLC
03 June 2020
Β 

Β 

Dialight plc (the "Group" or "Dialight")

CFO appointment

Dialight plc (LSE: DIA.L), the global leader in sustainable LED lighting for industrial applications, is pleased to announce the appointment of Wai Kuen Chiang as Chief Financial Officer ("CFO") and executive director of the Group. The effective date of Wai Kuen's appointment will be announced in due course, reflecting the notice period with her current employer. Her appointment follows a thorough recruitment process led by the Board.

Wai Kuen brings nearly 30 years of experience in large listed multinationals in the industrial manufacturing and electronic sectors, most recently as Group Financial Controller of Coats Group plc, a FTSE 250 company. Over her nine years in Coats, she has held a number of senior global and regional finance roles before moving onto a corporate role in 2017.

Prior to Coats, Wai Kuen's career has included working for the Goodrich Corporation, Canon Inc, Technicolor and Gardner Denver. Wai Kuen has a Bachelor of Accountancy from the National University of Singapore and qualified as a chartered accountant with Ernst & Young. There are no further matters to be disclosed pursuant to Listing Rule LR 9.6.13 R.

Wai Kuen will succeed interim CFO Ronan Sheehy.

Fariyal Khanbabi, CEO, commented:

"We are delighted to welcome Wai Kuen to the Dialight team. She has significant financial and commercial experience at a number of leading international businesses, and we look forward to her assistance in driving the Dialight strategy forward."

Β 

Contacts:Β 

Dialight plc

Tel: +44 (0)203 058 3542

Fariyal Khanbabi - Group Chief Executive

Richard Allan - General Counsel & Company Secretary

Β 

About Dialight:Β 

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment. The company is headquartered in the UK with operations in the USA, UK, Germany, Malaysia, Singapore, Australia, Mexico, Dubai and Brazil. www.dialight.com.

Β 

Notes:

1. This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations. On the publication of this announcement via a Regulatory Information Service ("RIS"), this information is considered to be in the public domain.

2. The person responsible for making this announcement is Richard Allan, General Counsel & Company Secretary of Dialight plc

Β 

LEI: 2138001AD31KKD29Z495

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAUPUMCQUPUGQP
Date   Source Headline
8th Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report
11th Nov 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.